Sectors

The developer of T-cell receptor therapies backed by Boehringer Ingelheim raised a series B round which will be used to boost its manufacturing capacity and advance its pipeline of candidates.

Abico Group, Gree, Mixi and Otto Group are all among the LPs that helped the venture firm close its fourth fund, which is set to back about 40 Asia-based internet, e-commerce and fintech startups.

The industrial sensor manufacturer spun out of Michigan and Virginia has increased its latest round to $51m in a tranche backed by 3M, Ericsson and Armstrong International.

Corporate-backed teleconferencing system provider Baijiayun raised cash at a $465m valuation while financial software provider Prime Trust closed a $64m round featuring Nationwide and Samsung Next.

UW's vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.

The GV-backed cardiovascular therapeutics company has priced an upsized offering on Nasdaq, with the shares closing just marginally higher on the first day.

UPMC Enterprises has contributed to a $117m series B round for gene therapy developer Ring Therapeutics.

Only five months after closing a $541m series A round, SVolt has closed a $1.58bn series B backed by investors including Xiaomi and Sany.

SoftBank’s Vision Fund returned for the $1bn funding round that valued the personal services platform operator at $15bn.

Info Edge, Intel, SoftBank and Tencent are all in line for exits as PolicyBazaar files for an initial public offering in India.

Bolt is valued at more than $4.75bn following a $713m funding round, although its corporate backers did not return for the transaction.